Cell MedX (CMXC) News Today $0.27 0.00 (0.00%) As of 09/8/2025 Add Compare Share Share Headlines Stock AnalysisChartSEC FilingsBuy This Stock CMXC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period StimCell Energetics Inc. (CMXC)November 27, 2024 | finance.yahoo.comCell MedX Corp. (CMXC)October 24, 2024 | finance.yahoo.comThe best cell phone plans in 2024April 2, 2024 | businessinsider.comCells, organ systems and ecosystemsMarch 29, 2024 | bbc.co.ukCMXC Cell MedX Corp.March 29, 2024 | seekingalpha.comCell structure - AQA MicroscopesFebruary 14, 2024 | bbc.co.ukCell biologyFebruary 14, 2024 | bbc.co.ukCell MedX Corp CMXCJanuary 10, 2024 | morningstar.comMCell MedX Corp. Announces New CEO and Directors and Debt SettlementDecember 19, 2023 | finance.yahoo.comCell MedX Corp. Announces Full Revocation of British Columbia Cease Trade OrderNovember 27, 2023 | finance.yahoo.comCell MedX says COO Costa resigns from the roleNovember 9, 2023 | msn.comCell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating OfficerNovember 9, 2023 | finance.yahoo.comThe best cheap cell phone plans in 2023November 2, 2023 | businessinsider.comCells of the nervous system, neurotransmitters at synapsesSeptember 21, 2023 | bbc.co.ukChemical cellsSeptember 11, 2023 | bbc.co.ukChemical cells and fuel cellsSeptember 11, 2023 | bbc.co.ukThe cell membraneSeptember 10, 2023 | bbc.co.ukMitosis and the cell cycleApril 27, 2023 | bbc.co.ukDivision and differentiation in human cellsMarch 28, 2023 | bbc.co.ukCells and ReproductionFebruary 11, 2023 | bbc.co.ukBest Cell Phone Plans of 2022October 9, 2022 | usnews.com3 Different Types of Fat Cells and How to Lose ThemOctober 2, 2022 | yahoo.comFDA Submission and Corporate UpdateSeptember 20, 2022 | finance.yahoo.comCell MedX Corp: Letter to Shareholders from Mr. Dwayne Yaretz, CEOJune 27, 2022 | finance.yahoo.comCell MedX names new CEOApril 27, 2022 | seekingalpha.comCell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and DirectorApril 27, 2022 | finance.yahoo.comCell MedX Corp. to Attend the 29th Annual Wellness Show 2022 Held in Vancouver, BCMarch 24, 2022 | finance.yahoo.comFDA Commences Review of Cell MedX's Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) SystemsNovember 15, 2021 | finance.yahoo.comCell MedX Corp. Files Premarket Notification (510K) with the US Food and Drug Administration and Receives Canadian TrademarkSeptember 17, 2021 | finance.yahoo.com Get Cell MedX News Delivered to You Automatically Sign up to receive the latest news and ratings for CMXC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CMXC Media Mentions By Week CMXC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMXC News Sentiment▼0.000.84▲Average Medical News Sentiment CMXC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMXC Articles This Week▼00▲CMXC Articles Average Week Get the Latest News and Ratings for CMXC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cell MedX and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ABLE News AASP News ABWN News ANCTF News CACH News FTEG News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CMXC) was last updated on 9/11/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cell MedX Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cell MedX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
